IMMUNOLOCALIZATION OF BCL-2 IN THE HUMAN CORPUS-LUTEUM

被引：43

作者：

RODGER, FE

FRASER, HM

DUNCAN, WC

ILLINGWORTH, PJ

机构：

[1] MRC Reproductive Biology Unit, Centre for Reproductive Biology, Edinburgh EH3 9EW

来源：

HUMAN REPRODUCTION | 1995年 / 10卷 / 06期

基金：

英国惠康基金;

关键词：

APOPTOSIS; BCL-2; CORPUS LUTEUM; GRANULOSA; 17-ALPHA-HYDROXYLASE;

D O I：

10.1093/HUMREP/10.6.1566

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The mechanisms of luteal regression and rescue in women are unknown but forms of programmed cell death may be involved. The proto-oncogene bcl-2 is an important inhibitor of apoptosis but has not previously been described in the human corpus luteum. Immunohistochemical localization of bcl-2 protein was investigated in human corpora lutea obtained from women undergoing surgery during endocrine monitored menstrual cycles as well as from women who had been treated with human chorionic gonadotrophin (HCG) to prolong the luteal phase, Bcl-2 was found to be localized in granulosa-lutein, theca-lutein (as identified by co-localization of P450(17 alpha-hydroxylase)) and the endothelial cells around some blood vessels. Immunoblotting demonstrated the presence of a single band of similar to MW 26 kDa. There was no apparent change in either the intensity of immunostaining or the histological localization during the normal luteal phase or following treatment with human chorionic gonadotrophin. The product of the proto-oncogene bcl-2 is present in the human corpus luteum, It is unlikely that bcl-2 expression alone is responsible for prolongation of the lifespan of the corpus luteum in early pregnancy although it is possible that the action of the bcl-2 gene present is modified by changes in other members of the bcl-2 family.

引用

页码：1566 / 1570

页数：5

共 26 条

[1]

Behrman H.R., Endo T., Aten R.F., Musicki B., Corpus luteum function and regression. Reprod. Med, Rev., 2, pp. 153-180, (1993)

[2]

Bissonette R.R., Echeverri F., Mahboubi A., Apoptotic cell death induced by c-myc is inhibited by bcl-2, Nature, 359, pp. 552-554, (1992)

[3]

Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., C.B. (1993) bcl-x, a 6c/-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, 74, pp. 597-608

[4]

Bradford M.M., A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal, Biochem., 72, pp. 248-254, (1976)

[5]

Djahanbakhch O., McNeilly A.S., Hobson B.M., Templeton A.A., A rapid luteinizing hormone radioimmunoassay for the prediction of ovulation, Br. J. Obstet. Gynaecol., 88, pp. 1016-1020, (1981)

[6]

Gillim S.W., Christensen K.A., McLennan C.E., Fine structure of the human menstrual corpus luteum at its stage of maximum secretory activity, Am. J. Anat., 126, pp. 409-428, (1969)

[7]

Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J., Bel-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348, pp. 334-336, (1990)

[8]

Illingworth P.J., Reddi K., Smith K., Baird D.T., Pharmacologic ‘rescue’ of the corpus luteum results in increased inhibin production. Clin, Endocrinol., 33, pp. 323-332, (1990)

[9]

Illingworth P.J., Fraser H.M., Young F.M., Lunn S.F., Cowen G.M., Localisation of C-Myc in the Human Corpus Luteum, (1994)

[10]

Juengel J.L., Garverick H.A., Johnson A.L., Youngquist R.S., Smith M.F., Apoptosis during luteal regression in cattle, Endocrinology, 132, pp. 249-254, (1993)

← 1 2 3 →